Curis
CRIS
#11081
Rank
โ‚น64.43 M
Marketcap
โ‚น33.06
Share price
-17.89%
Change (1 day)
-76.75%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น2.83 Billion

According to Curis's latest financial reports the company's total assets are โ‚น2.83 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚น1.79 B-49.37%
2024-12-31โ‚น3.53 B-44.98%
2023-12-31โ‚น6.43 B-28.57%
2022-12-31โ‚น9.00 B-25.44%
2021-12-31โ‚น12.08 B-19.17%
2020-12-31โ‚น14.94 B496.98%
2019-12-31โ‚น2.50 B-4.18%
2018-12-31โ‚น2.61 B-44.55%
2017-12-31โ‚น4.71 B20.07%
2016-12-31โ‚น3.92 B-37.81%
2015-12-31โ‚น6.31 B59.03%
2014-12-31โ‚น3.96 B-20.3%
2013-12-31โ‚น4.97 B30.34%
2012-12-31โ‚น3.82 B49.88%
2011-12-31โ‚น2.54 B12.3%
2010-12-31โ‚น2.26 B35.5%
2009-12-31โ‚น1.67 B-12.84%
2008-12-31โ‚น1.92 B-9.01%
2007-12-31โ‚น2.11 B-8.77%
2006-12-31โ‚น2.31 B-15.55%
2005-12-31โ‚น2.74 B-6%
2004-12-31โ‚น2.91 B14.91%
2003-12-31โ‚น2.53 B-15.25%
2002-12-31โ‚น2.99 B-57.13%
2001-12-31โ‚น6.98 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚น19.804 T 699,280.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.248 T 291,202.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น10.27 B 262.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น247.40 B 8,636.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น48.76 B 1,622.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น1.68 B-40.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น125.95 B 4,347.89%๐Ÿ‡บ๐Ÿ‡ธ USA